Mergen Ltd Settles Patent Litigation with OxfordGene

by Stephen Jenei
January 20, 2005

Mergen Limited announced it has resolved its patent infringement litigation case with Oxford Gene Technology.  Under the terms of the settlement, Mergen has obtained a license from OGT for its expression chips in the U.S., Europe and Japan.  This license allows Mergen to manufacture and sell microarrays, e.g., Mergen’s ExpressChip(TM) DNA microarray system for high-throughput, high-sensitivity gene expression profiling.   See the Press Release.

Related posts:

  1. St. Jude Medical Settles Heart Valve Patent suit with Edwards Lifesciences
  2. GenoMed Announces Patent Application on Genes Linked to Cancers.
  3. Ex-Employee Settles Patent Dispute with Japanese Company for $8.1 Million
  4. Patent Application for Purified DNA Held Anticipated Inventor’s Publications

Posted in: IP Litigation
Print This Post Print This Post  
« | »

Comments are closed.